A Study of DCR-PH1 in Patients With Primary Hyperoxaluria Type 1 (PH1)

Name: A Study of DCR-PH1 in Patients With Primary Hyperoxaluria Type 1 (PH1)
Published: 2016
License: Public Domain

Dicerna Pharmaceuticals, Inc., a Novo Nordisk company · 2016

ClinicalTrials.gov · Datasets · License: Public Domain · 2016

Open Source ↗

genetic-diseases metabolic-diseases

primary hyperoxaluria type 1, ph1, calcium oxalate stones, kidney stones, liver enzyme deficiency, genetic diseases, inborn kidney diseases, metabolic diseases, inborn errors, urological diseases, carbohydrate metabolism, hyperoxaluria

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 908572
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.